Prediction of tumor heterogeneity in localized prostate cancer.

Clinical T1 and T2 prostatic carcinoma is a heterogeneous tumor with respect to pathologic stage and outcome. In the authors' experience, 60% of patients have a pT2 prostatic carcinoma, and 2% to 4% have tumors less than 0.5 cm3 in volume. The latter group cannot be predicted by the use of preo...

Повний опис

Бібліографічні деталі
Автори: Huland, H, Graefen, M, Haese, A, Hammerer, P, Palisaar, J, Pichlmeier, U, Henke, R, Erbersdobler, A, Huland, E, Lilja, H
Формат: Journal article
Мова:English
Опубліковано: 2002